Report an error

Spotted something inaccurate in “Phase 3 Trial Validates ADC Therapy for Relapsed Small-Cell Lung Cancer”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.